ID

13887

Descripción

Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance; ODM derived from: https://clinicaltrials.gov/show/NCT01240252

Link

https://clinicaltrials.gov/show/NCT01240252

Palabras clave

Versiones (1)
  1. 13/3/16 13/3/16 -
Subido en

13 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes Mellitus NCT01240252

Inglés

Eligibility Type 2 Diabetes Mellitus NCT01240252

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 30-65 y
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
healthy lean, obese, or known type 2 diabetic
Descripción

diabetes mellitus type 2

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
body mass index (bmi) less than 36
Descripción

body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
all nondiabetic subjects must have normal oral glucose tolerance
Descripción

Oral Glucose Tolerance Test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029161
subjects must have the following laboratory values:
Descripción

laboratory parameters

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022885
1. hematocrit ≥ 35 vol%
Descripción

hematocrit

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518014
2. serum creatinine ≤ 1.6 mg/dl
Descripción

serum creatinine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
3. aspartate aminotransferase (ast) (sgot)< 2 times upper limit of normal
Descripción

aspartate aminotransferase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
4. alanine aminotransferase (alt) (sgpt)< 2 times upper limit of normal
Descripción

alanine aminotransferase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201836
5. alkaline phosphatase < 2 times upper limit of normal
Descripción

alkaline phosphatase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201850
6. triglycerides < 150 mg/dl
Descripción

triglycerides

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202236
7. prothrombin time (pt) 11.7 -14.3 seconds
Descripción

prothrombin time

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0491338
8. partial thromboplastin time 23.0-37.0 seconds
Descripción

partial thromboplastin time

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3525810
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
no diseases known to affect glucose metabolism other than healthy type 2 diabetes
Descripción

glucose metabolism; diabetes mellitus type 2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0596620
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C0441730
subjects must not be receiving any of the following medications: thiazide or furosemide diuretics, beta-blockers, or other chronic medications with known adverse effects on glucose tolerance levels unless the patient has been on stable dose of such agents for the past three months before entry into the study. subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months. subjects taking systemic glucocorticoids are excluded.
Descripción

Thiazide Diuretics; beta-blockers; estrogens therapy; systemic glucocorticoids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012802
UMLS CUI [2]
C0001645
UMLS CUI [3]
C3541386
UMLS CUI [4]
C3540777
subjects with a history of clinically significant heart disease (new york heart classification greater than grade ii; more than non-specific st-t wave changes on the ekg), peripheral vascular disease (history of claudication), or pulmonary disease (dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation) will not be studied.
Descripción

heart disease; nyha classification; peripheral vascular disease; pulmonary disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C1275491
UMLS CUI [3]
C0085096
UMLS CUI [4]
C0024115
recent systemic or pulmonary embolus, untreated high-risk proliferative retinopathy, recent retinal hemorrhage, uncontrolled hypertension, systolic bp>180, diastolic bp>105, autonomic neuropathy, resting heart rate >100, electrolyte abnormalities.
Descripción

Pulmonary Embolism; retinopathy; retinal hemorrhage; uncontrolled hypertension; blood pressure; neuropathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0034065
UMLS CUI [2]
C0035309
UMLS CUI [3]
C0035317
UMLS CUI [4]
C1868885
UMLS CUI [5]
C0005823
UMLS CUI [6]
C0442874
Volver a la parte superior de la página

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01240252

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age 30-65 y
boolean
C0001779 (UMLS CUI [1])
diabetes mellitus type 2
Item
healthy lean, obese, or known type 2 diabetic
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
body mass index
Item
body mass index (bmi) less than 36
boolean
C1305855 (UMLS CUI [1])
Oral Glucose Tolerance Test
Item
all nondiabetic subjects must have normal oral glucose tolerance
boolean
C0029161 (UMLS CUI [1])
laboratory parameters
Item
subjects must have the following laboratory values:
boolean
C0022885 (UMLS CUI [1])
hematocrit
Item
1. hematocrit ≥ 35 vol%
boolean
C0518014 (UMLS CUI [1])
serum creatinine
Item
2. serum creatinine ≤ 1.6 mg/dl
boolean
C0201976 (UMLS CUI [1])
aspartate aminotransferase
Item
3. aspartate aminotransferase (ast) (sgot)< 2 times upper limit of normal
boolean
C0201899 (UMLS CUI [1])
alanine aminotransferase
Item
4. alanine aminotransferase (alt) (sgpt)< 2 times upper limit of normal
boolean
C0201836 (UMLS CUI [1])
alkaline phosphatase
Item
5. alkaline phosphatase < 2 times upper limit of normal
boolean
C0201850 (UMLS CUI [1])
triglycerides
Item
6. triglycerides < 150 mg/dl
boolean
C0202236 (UMLS CUI [1])
prothrombin time
Item
7. prothrombin time (pt) 11.7 -14.3 seconds
boolean
C0491338 (UMLS CUI [1])
partial thromboplastin time
Item
8. partial thromboplastin time 23.0-37.0 seconds
boolean
C3525810 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
glucose metabolism; diabetes mellitus type 2
Item
no diseases known to affect glucose metabolism other than healthy type 2 diabetes
boolean
C0596620 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0441730 (UMLS CUI [2,2])
Thiazide Diuretics; beta-blockers; estrogens therapy; systemic glucocorticoids
Item
subjects must not be receiving any of the following medications: thiazide or furosemide diuretics, beta-blockers, or other chronic medications with known adverse effects on glucose tolerance levels unless the patient has been on stable dose of such agents for the past three months before entry into the study. subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months. subjects taking systemic glucocorticoids are excluded.
boolean
C0012802 (UMLS CUI [1])
C0001645 (UMLS CUI [2])
C3541386 (UMLS CUI [3])
C3540777 (UMLS CUI [4])
heart disease; nyha classification; peripheral vascular disease; pulmonary disease
Item
subjects with a history of clinically significant heart disease (new york heart classification greater than grade ii; more than non-specific st-t wave changes on the ekg), peripheral vascular disease (history of claudication), or pulmonary disease (dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation) will not be studied.
boolean
C0018799 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
C0085096 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
Pulmonary Embolism; retinopathy; retinal hemorrhage; uncontrolled hypertension; blood pressure; neuropathy
Item
recent systemic or pulmonary embolus, untreated high-risk proliferative retinopathy, recent retinal hemorrhage, uncontrolled hypertension, systolic bp>180, diastolic bp>105, autonomic neuropathy, resting heart rate >100, electrolyte abnormalities.
boolean
C0034065 (UMLS CUI [1])
C0035309 (UMLS CUI [2])
C0035317 (UMLS CUI [3])
C1868885 (UMLS CUI [4])
C0005823 (UMLS CUI [5])
C0442874 (UMLS CUI [6])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial